- Time of issue:2021-11-19 17:54:55
The predecessor of Hunan Gaosheng Biological Technology Co., Ltd. was the Chinese Herbal Pieces Factory of Linxiang Medicinal Materials Company. Since 1995, it has been mainly engaged in the processing of wormwood. In 2004, it was restructured. It is now located in Wuli Street, Linxiang City, Yueyang City, with a land area of 121 acres, with 8 workshops and a building area of 8,800 square meters. The company has 155 employees, 2 automatic wormwood processing production lines, 4000 tons of wormwood processing capacity, 8 sets of automatic wormwood product production equipment; 1 set of Chinese herbal medicine equipment and supporting testing center, which can process 46 varieties; medical moxibustion equipment One production line with an annual output of 20,000 units.
In 2016, the company obtained the "Pharmaceutical Production License of the People's Republic of China" and the "Pharmaceutical GMP Certificate of the People's Republic of China", and all moxa products were included in the GMP certification; then in 2020, it obtained the production license for medical devices and sterilization products. At present, the only "three-certificate management" enterprise in the wormwood industry; the company has 13 patents and 4 brands (1 of which is a national famous brand).
So far, the company has sold more than 110 kinds of moxibustion products and Chinese herbal medicines at home and abroad. Moxa moxibustion products are sold to Japan (cooperating with 24 products of three Japanese companies), South Korea and other countries and more than 20 provinces and cities. , Has formed a complete wormwood industry chain including wormwood planting, purchase, storage, processing, moxibustion products, moxibustion equipment and appliances, moxibustion training and moxibustion health care. It is a new material enterprise, high-tech enterprise, small giant enterprise in Hunan Province, and a leading enterprise in agricultural industrialization in Yueyang City.
The antibacterial products of Aixiang and Chinese medicine formula jointly developed by the company and the National Center for Disease Control and Prevention have been tested by the National Center for Disease Control and Prevention, and the antibacterial rate can reach 86.3-94.3%. The product produces smoke through combustion to the bacteria that are harmful to human health (such as Glucococcus aureus, Escherichia coli, etc.) that are harmful to human health. It has a very significant effect of sterilizing and improving the space environment, and it fills the non-chemical substances in the indoor activity space of our country. Disinfect the blank. It can also be used for indoor disinfection, deodorization, mosquito repellent, etc. It can inhibit the spread of influenza and other bacteria and viruses in the air. It has a good auxiliary effect on the prevention of SARS, new crown virus, avian influenza, chickenpox, mumps and other respiratory infectious diseases.
The company has established a strong "industry-university-research system" with China CDC, Hunan University of Traditional Chinese Medicine School of Acupuncture, Hunan University of Traditional Chinese Medicine Affiliated First Hospital Acupuncture Department, Hunan Agricultural University College of Biology, College of Botany, Hunan Acupuncture and Moxibustion Society, Hunan Traditional Chinese Medicine Research The Institute, the Hunan Traditional Chinese Medicine Industry Association, the Medicinal Plant Research Center of the Hunan Academy of Agricultural Sciences, the Yueyang Vocational and Technical College, and the Yueyang Academy of Agricultural Sciences have established strategic cooperation or technical cooperation. Hunan Acupuncture and Moxibustion Association supervises the production of all products of the company.
With the support of the interdisciplinary expert team of Yueyang Vocational and Technical College, the company has made use of its qualifications, venues and product quality advantages to carry out strategic cooperation with the Millennium Chinese Medicine and Health Industry Group of Zhengzhou City, Henan Province. It is planned to invest 100 million to produce the medical version of the intelligent penetrating moxibustion device, with an annual output of 20,000 units, and supporting the production of medical consumables (Medical penetrating moxibustion device moxibustion device moxibustion). The current civilian version is produced, and the medical version will be produced in three months. With the support of Yueyang Health Commission, the company cooperates with Yueyang Traditional Chinese Medicine Hospital (jointly working with medicine and medicine), and is connecting with Yueyang Medical Consortium, and will be within the scope of Yueyang City. Approximately 200 million yuan products of Chinese medicine decoction pieces and in-hospital preparations in medical institutions will be produced by the company. Basically, the production structure of "Traditional Chinese Medicine 1+4" has been formed around the qualifications of Chinese medicine, lengthened, broadened, and cultivated (that is, traditional moxa products + medical moxibustion instrument and medical moxibustion instrument consumables + traditional Chinese medicine decoction pieces and hospital preparations). The output value is expected to reach 300-500 million yuan in 2022 and 600 million yuan in 2023.
The company has signed cooperation agreements with wormwood planting enterprises in various cities and prefectures in Hunan Province, "signing in advance and acquiring at a guaranteed minimum" to promote the cultivation of 10,000 mu of wormwood. It will reach 50,000 mu by 2023 to ensure the export of moxa products and the exclusive supply of Chinese medicine hospital system.
Scan the QR code to read on your phone